Nu Skin Enterprises (NUS) Asset Writedowns and Impairment (2021 - 2025)

Nu Skin Enterprises (NUS) has 5 years of Asset Writedowns and Impairment data on file, last reported at $22.3 million in Q4 2025.

• For the quarter ending Q4 2025, Asset Writedowns and Impairment fell 53.84% year-over-year to $22.3 million; the trailing twelve-month figure through Mar 2026 stood at $25.0 million (down 51.24% YoY), and the FY2025 full-year result was $28.1 million, down 41.73% from the prior year.
• Asset Writedowns and Impairment climbed to $22.3 million in Q4 2025, from -$22.2 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $83.6 million in Q3 2023 to a low of -$83.6 million in Q4 2023.
• A 5-year average of $4.3 million and a median of $3.3 million in 2023 frame the typical range for Asset Writedowns and Impairment.
• Peak annual rise in Asset Writedowns and Impairment reached 610.0% in 2025, while the deepest fall reached 531.65% in 2025.
• Tracing NUS's Asset Writedowns and Impairment over 5 years: stood at $9.0 million in 2021, then plunged by 429.58% to -$29.7 million in 2022, then sank by 181.98% to -$83.6 million in 2023, then jumped by 157.65% to $48.2 million in 2024, then plunged by 53.84% to $22.3 million in 2025.
• Business Quant data shows NUS's Asset Writedowns and Impairment at $22.3 million in Q4 2025, -$22.2 million in Q3 2025, and $25.0 million in Q2 2025.